A retrospective study of patients with cancer treated with anti-CTLA-4 and/or anti-PD-(L)1 therapies reported an incidence of ICI-induced exocrine pancreatic insufficiency of 1.18 cases per 1000 person-years, occurring without radiological features of chronic pancreatitis [61]. The gene discussed is CD274; the disease is cancer.